Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2022

Open Access 01-12-2022 | Multiple Sclerosis | Research

Barriers to quality of life in patients with multiple sclerosis: a qualitative study

Authors: Zahra Hosseini, Atefeh Homayuni, Masoud Etemadifar

Published in: BMC Neurology | Issue 1/2022

Login to get access

Abstract

Background

Multiple sclerosis (MS) is a chronic progressive disease of the central nervous system that affects the patients’ quality of life. This research was conducted with the aim of identifying the barriers of quality of life in patients with MS.

Methods

This qualitative study was conducted through a conventional content analysis approach. We used the purposeful sampling with maximum diversity in terms of gender, age, education, marital status and employment. Data were collected through semi-structured interviews with 18 patients with multiple sclerosis referred to the MS Association of Isfahan. Interviews were conducted to the point of information saturation.

Results

Through the content analysis of the interviews, we identified 2 main categories and 11 sub-categories. The main categories include intrapersonal problems (physical problems, psychological disorders, turbulent future, functional limitations, job loss and pennilessness), and environmental barriers (disease and treatment process, fatigue of caregivers, information deficiency about MS, family tensions, lack of social support and fun and entertainment).

Conclusions

In order to improve the quality of life in these patients, there is a need for attention and practical measures in the field of identified factors. By removing barriers such as providing educational and counseling services to the patients and their families, adapting the urban structure, providing financial support and adequate insurance coverage, the authorities can take measures to ensure patients’ health and improve their quality of life.
Literature
1.
Bansi J, Bloch W, Gamper U, Kesselring J. Training in MS: influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial. Mult Scler J. 2013;19(5):613–21.CrossRef
2.
Cameron MH, Wagner JM. Gait abnormalities in multiple sclerosis: pathogenesis, evaluation, and advances in treatment. Curr Neurol Neurosci Rep. 2011;11(5):507–15.PubMedCrossRef
3.
Milo R, Miller A. Revised diagnostic criteria of multiple sclerosis. Autoimmun Rev. 2014;13(4–5):518–24.PubMedCrossRef
4.
Morgante L. Hope in multiple sclerosis: a nursing perspective. Int J MS Care. 2000;2(2):9–15.CrossRef
5.
Kanter JW, Baruch DE, Gaynor ST. Acceptance and commitment therapy and behavioral activation for the treatment of depression: Description and comparison. Behav Anal. 2006;29(2):161–85.PubMedPubMedCentralCrossRef
6.
Bishop M, Stenhoff DM, Shepard L. Psychosocial adaptation and quality of life in multiple sclerosis: assessment of the disability centrality model. J Rehabil. 2007;73(1):3–12
7.
Blanco-Rivera C, Capeans-Tome C, Otero-Cepeda X. Quality of life in patients with choroidal melanoma. Arch Soc Esp Oftalmol. 2008;83(5):301–6.PubMed
8.
Benedict RH, Wahlig E, Bakshi R, Fishman I, Munschauer F, Zivadinov R, et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci. 2005;231(1–2):29–34.PubMedCrossRef
9.
Miller A, Dishon S. Health-related quality of life in multiple sclerosis: the impact of disability, gender and employment status. Qual Life Res. 2006;15(2):259–71.PubMedCrossRef
10.
Karatepe AG, Kaya T, Günaydn R, Demirhan A, Çe P, Gedizlioglu M. Quality of life in patients with multiple sclerosis: the impact of depression, fatigue, and disability. Int J Rehabil Res. 2011;34(4):290–8.CrossRef
11.
Domingo S, Kinzy T, Thompson N, Gales S, Stone L, Sullivan A. Factors associated with sexual dysfunction in individuals with multiple sclerosis: implications for assessment and treatment. Int J MS Care. 2018;20(4):191–7.PubMedPubMedCentralCrossRef
12.
Amtmann D, Askew RL, Kim J, Chung H, Ehde DM, Bombardier CH, et al. Pain affects depression through anxiety, fatigue, and sleep in multiple sclerosis. Rehabil Psychol. 2015;60(1):81.PubMedPubMedCentralCrossRef
13.
Zivadinov R, Sepcic J, Nasuelli D, De Masi R, Bragadin LM, Tommasi M, et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry. 2001;70(6):773–80.PubMedPubMedCentralCrossRef
14.
Strober L. Quality of life and psychological well-being in the early stages of multiple sclerosis (MS): Importance of adopting a biopsychosocial model. Disabil Health J. 2018;11(4):555–61.PubMedPubMedCentralCrossRef
15.
Thompson AJ, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73.PubMedCrossRef
16.
Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24(2):105–12.PubMedCrossRef
17.
Amtmann D, Bamer AM, Kim J, Chung H, Salem R. People with multiple sclerosis report significantly worse symptoms and health related quality of life than the US general population as measured by PROMIS and NeuroQoL outcome measures. Disabil Health J. 2018;11(1):99–107.PubMedCrossRef
18.
Forbes A, While A, Mathes L, Griffiths P. Health problems and health-related quality of life in people with multiple sclerosis. Clin Rehabil. 2006;20(1):67–78.PubMedCrossRef
19.
20.
Dividson S. The efficacy of cognitive behavioral group therapy on quality of insomnia and resilience of multiple sclerosis. Behavior Res Therapy. 2014;46:487–95.
21.
Yozbatıran N, Baskurt F, Baskurt Z, Ozakbas S, Idiman E. Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients. J Neurol Sci. 2006;246(1–2):117–22.PubMedCrossRef
22.
Kern S, Schrempf W, Schneider H, Schultheiss T, Reichmann H, Ziemssen T. Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis. Mult Scler J. 2009;15(6):752–8.CrossRef
23.
Greeke EE, Chua AS, Healy BC, Rintell DJ, Chitnis T, Glanz BI. Depression and fatigue in patients with multiple sclerosis. J Neurol Sci. 2017;380:236–41.PubMedCrossRef
24.
Silveira C, Guedes R, Maia D, Curral R, Coelho R. Neuropsychiatric symptoms of multiple sclerosis: state of the art. Psychiatry Investig. 2019;16(12):877.PubMedPubMedCentralCrossRef
25.
Berrigan LI, Fisk JD, Patten SB, Tremlett H, Wolfson C, Warren S, et al. Health-related quality of life in multiple sclerosis: direct and indirect effects of comorbidity. Neurology. 2016;86(15):1417–24.PubMedPubMedCentralCrossRef
26.
27.
McKay KA, Tremlett H, Fisk JD, Zhang T, Patten SB, Kastrukoff L, et al. Psychiatric comorbidity is associated with disability progression in multiple sclerosis. Neurology. 2018;90(15):e1316–23.PubMedPubMedCentralCrossRef
28.
Théaudin M, Romero K, Feinstein A. In multiple sclerosis anxiety, not depression, is related to gender. Mult Scler J. 2016;22(2):239–44.CrossRef
29.
Borisow N, Döring A, Pfueller CF, Paul F, Dörr J, Hellwig K. Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy. EPMA J. 2012;3(1):1–10.CrossRef
30.
Popp JM, Robinson JL, Britner PA, Blank TO. Parent adaptation and family functioning in relation to narratives of children with chronic illness. J Pediatr Nurs. 2014;29(1):58–64.PubMedCrossRef
31.
Janssens AC, Van Doorn P, De Boer J, Kalkers N, van der Meché FG, Passchier J, et al. A nxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Mult Scler J. 2003;9(4):397–403.CrossRef
32.
Kalb RC. Multiple sclerosis: The questions you have, the answers you need. New York: Demos Medical Publishing; 2011.
33.
Halper J. The psychosocial effect of multiple sclerosis: the impact of relapses. J Neurol Sci. 2007;256:S34–8.PubMedCrossRef
34.
Huijbregts SC, Kalkers NF, de Sonneville LM, de Groot V, Polman CH. Cognitive impairment and decline in different MS subtypes. J Neurol Sci. 2006;245(1–2):187–94.PubMedCrossRef
35.
Messmer Uccelli M, Specchia C, Battaglia M, Miller D. Factors that influence the employment status of people with multiple sclerosis: a multi-national study. J Neurol. 2009;256(12):1989–96.PubMedCrossRef
36.
Raggi A, Covelli V, Schiavolin S, Scaratti C, Leonardi M, Willems M. Work-related problems in multiple sclerosis: a literature review on its associates and determinants. Disabil Rehabil. 2016;38(10):936–44.PubMedCrossRef
37.
Pack TG, Szirony GM, Kushner JD, Bellaw JR. Quality of life and employment in persons with multiple sclerosis. Work. 2014;49(2):281–7.PubMedCrossRef
38.
Bøe Lunde HM, Telstad W, Grytten N, Kyte L, Aarseth J, Myhr K-M, et al. Employment among patients with multiple sclerosis-a population study. PLoS ONE. 2014;9(7):e103317.PubMedPubMedCentralCrossRef
39.
Adelman G, Rane SG, Villa KF. The cost burden of multiple sclerosis in the United States: a systematic review of the literature. J Med Econ. 2013;16(5):639–47.PubMedCrossRef
40.
Paschal AM, Ablah E, Wetta-Hall R, Molgaard CA, Liow K. Stigma and safe havens: a medical sociological perspective on African-American female epilepsy patients. Epilepsy Behav. 2005;7(1):106–15.PubMedCrossRef
41.
Chang SLSKJ, Kim S. Coping of patients undergoing hemodialysis. Asi J Nurs Stud. 2003;2(2):40–50.
42.
Hadianfard H, Ashjazadeh N, Feridoni S, Farjam E. The role of psychological resilience, severity of disease and treatment adherence in the prediction of health-related quality of life in patients with multiple sclerosis. Neurol Asia. 2015;20(3):263–68.
43.
Miniszewska J, Juczyński Z, Sysa-Jędrzejowska A, Zalewska A, Woźniacka A. Predictors of life quality in patients with systemic lupus erythematosus. Przegl Lek. 2006;63(4):188–90.PubMed
44.
Samkoff LM. Multiple sclerosis: update on treatment. Hosp Physician. 2002;38(3):21–32.
45.
46.
Holicky R. A labor of love beating stress in long-term caregiving. New media & Degnan co. 2000;24(1):29–34.
47.
Chen PS, Yang YK, Liao YC, Lee YD, Yeh TL, Cheng CC. The psychological well-being and associated factors of caregivers of outpatients with schizophrenia in Taiwan. Psychiatry Clin Neurosci. 2004;58(6):600–5.PubMedCrossRef
48.
Hung L-C, Liu C-C, Hung H-C, Kuo H-W. Effects of a nursing intervention program on disabled patients and their caregivers. Arch Gerontol Geriatr. 2003;36(3):259–72.PubMedCrossRef
49.
de Seze J, Borgel F, Brudon F. Patient perceptions of multiple sclerosis and its treatment. Patient Prefer Adherence. 2012;6:263.PubMedPubMedCentral
50.
Porcelli B, Pozza A, Bizzaro N, Fagiolini A, Costantini M-C, Terzuoli L, et al. Association between stressful life events and autoimmune diseases: a systematic review and meta-analysis of retrospective case–control studies. Autoimmun Rev. 2016;15(4):325–34.PubMedCrossRef
51.
Abdollahpour I, Nedjat S, Mansournia MA, Eckert S, Weinstock-Guttman B. Stress-full life events and multiple sclerosis: a population-based incident case-control study. Multiple Scler Relat Disord. 2018;26:168–72.CrossRef
52.
Saul A, Ponsonby A-L, Lucas RM, Taylor BV, Simpson S Jr, Valery P, et al. Stressful life events and the risk of initial central nervous system demyelination. Mult Scler J. 2017;23(7):1000–7.CrossRef
53.
Kristofferzon ML, Löfmark R, Carlsson M. Coping, social support and quality of life over time after myocardial infarction. J Adv Nurs. 2005;52(2):113–24.PubMedCrossRef
54.
Patel SS, Peterson RA, Kimmel PL, editors. Psychosocial factors in patients with chronic kidney disease: The impact of social support on end‐stage renal disease. Seminars in dialysis: Wiley Online Library; 2005.
55.
Krokavcova M, van Dijk JP, Nagyova I, Rosenberger J, Gavelova M, Middel B, et al. Social support as a predictor of perceived health status in patients with multiple sclerosis. Patient Educ Couns. 2008;73(1):159–65.PubMedCrossRef
56.
Dehghani A, Nayeri ND, Ebadi A. Antecedents of coping with the disease in patients with multiple sclerosis: a qualitative content analysis. Int J Community Based Nurs Midwifery. 2017;5(1):49.
57.
Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS. Environmental risk factors and Parkinson’s disease: a metaanalysis. Environ Res. 2001;86(2):122–7.PubMedCrossRef
Metadata
Title
Barriers to quality of life in patients with multiple sclerosis: a qualitative study
Authors
Zahra Hosseini
Atefeh Homayuni
Masoud Etemadifar
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-022-02700-7

Other articles of this Issue 1/2022

BMC Neurology 1/2022 Go to the issue

Study protocol

Efficacy and safety of butylphthalide in secondary prevention of stroke: study protocol for a multicenter, real world trial based on Internet

Correction

Correction: Risk factors for aneurysm rupture among Kazakhs: findings from a national tertiary hospital

Research

Impact of COVID-19 infection among myasthenia gravis patients- a Cerner Real-World DataTM study

Research article

Technical note and first results on JET 7 thromboaspiration device for T-ICA occlusions

Case report

Ipsilateral blooming of microbleeds after Hyperintense Acute Reperfusion Marker sign in an ischemic Stroke patient, a case report

Research

Gamma-glutamyl transferase levels are associated with the occurrence of post-stroke cognitive impairment: a multicenter cohort study